Joint Venture Contract Sample Contracts

Aridis Pharmaceuticals, Inc. – Joint Venture Contract in Respect of Shenzhen Arimab Biopharmaceuticals Co., Ltd. (July 18th, 2018)

This Joint Venture Contract (this Contract) is entered into by and between the following parties on , 2018 in Shenzhen, the Peoples Republic of China.

NATUZZI TRADING (SHANGHAI) CO., LTD JOINT VENTURE CONTRACT BETWEEN Jason Furniture (Hangzhou) Co., Ltd. AND Natuzzi S.p.A (April 30th, 2018)

[***] This information is subject to confidential treatment and has been omitted and filed separately with the Securities and Exchange Commission.

China Automotive Systems, Inc. – Joint Venture Contract (April 27th, 2018)

CHAPTER 1 PREFACE 1 CHAPTER 2 DEFINITIONS 2 Article 1 Definitions 2 CHAPTER 3 GENERAL INFORMATION OF THE COMPANY 3 Article 2 Company Name and Legal Address 3 Article 3 Organization of the Company 4 Article 4 Subsidiaries and Affiliates 4 CHAPTER 4 PURPOSE, SCALE OF THE COMPANY AND BUSINESS SCOPE 4 Article 5 Purpose and Scale of the Company 4 Article 6 Business Scope 4 CHAPTER 5 OBLIGATIONS OF BOTH PARTIES 5 Article 7 Obligations of Both Parties 5 Article 8 Preparation Period 7 CHAPTER 6 REGISTERED CAPITAL 8 Article 9 Total Investment and Registered Capital 8 Article 10 Capital Contribution, Method and Term 8 Article 11 Capital Verification 9 Article 12 Shareholding Ratio 9 Article 13 Capital Contribution Certificate and Rights 9 Article 14 Equity Transfer 10 Article 15

Aridis Pharmaceuticals, Inc. – Joint Venture Contract in Respect of Shenzhen Arimab Biopharmaceuticals Co., Ltd. (April 20th, 2018)

This Joint Venture Contract (this Contract) is entered into by and between the following parties on , 2018 in Shenzhen, the Peoples Republic of China.

Kenon Holdings Ltd. – JOINT VENTURE CONTRACT Among Wuhu Chery Automobile Investment Co., Ltd. Quantum (2007) LLC and Hangzhou Chengmao Investment Co., Ltd. In Respect of Qoros Automotive Co., Ltd. DATE: December 20, 2017 (April 9th, 2018)

Wuhu Chery Automobile Investment Co., Ltd., a limited liability company duly organized and existing under the laws of the People's Republic of China ("PRC"), with its legal address at 8 Changchun Road, Wuhu Economic and Technological Development Area, Anhui Province, PRC (hereinafter referred to as "Party A");

Synthesis Energy Systems, Inc. – Joint Venture Contract (August 24th, 2017)

THIS JOINT VENTURE CONTRACT is entered into in accordance with the Law of the People's Republic of China on Chinese-Foreign Equity Joint Ventures and the Regulations for the Implementation of the Law of the People's Republic of China on Chinese-Foreign Equity Joint Ventures (the "Joint Venture Law") and other relevant and currently effective Chinese laws and regulations, and is amended on August 18, 2017 and entered into by the following three parties:

Bionik Laboratories Corp. – CO-OPERATIVE JOINT VENTURE CONTRACT Between GINGER CAPITAL INVESTMENT HOLDING, LTD. And BIONIK LABORATORIES CORP. With Respect to the Establishment of China Bionik Medical Rehabilitation Technology Ltd. May 17, 2017 (June 29th, 2017)

In accordance with the Law of the People's Republic of China on Chinese-Foreign Co-Operative Joint Venture Enterprises and its implementing regulations (hereinafter collectively referred to as the "CJV Law") and in conformity with other relevant Laws of the PRC, and adhering to the principles of equality and mutual benefit and through friendly consultations, Ginger Capital Investment Holding, Ltd of Hong Kong and Bionik Laboratory, Corp. of the USA agree to enter into this cooperative joint venture contract (this "Contract") to establish a co-operative joint venture enterprise in Beijing, the PRC, to carry on business activities as permitted by Law for the purposes set forth herein below.

BeiGene, Ltd. – CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [...***...]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE U.S. SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. AMENDED EQUITY JOINT VENTURE CONTRACT Regarding BEIGENE BIOLOGICS CO., LTD. Between BeiGene (Hong Kong) Co., Limited and Guangzhou GET Technology Development Co., Ltd. April 11, 2017 (May 10th, 2017)

WHEREAS, BeiGene (Hong Kong) Co., Limited., is a limited liability company established under the laws of the Hong Kong Special Administrative Region and registered in 13/F, Gloucester Tower, The Landmark, 15 Queens Road Central, Hong Kong (Party A);

Kite Pharma, Inc. – Sino-Foreign Co-Operative Joint Venture Contract (May 8th, 2017)

Whereas Kite is a clinical-stage biotechnology company engaged, through its Affiliates, in the research, development and commercialization of novel cellular and other immunotherapies, including for the treatment of cancer.

SPAR Group, Inc. – [Joint Venture Contract] (April 17th, 2017)

THIS CONTRACT ("Contract") is made in Shanghai, China on July 4th 2014 by and between SPAR China Inc, established and existing under the laws of Hong Kong, with its legal address at Room 3903, Tower 2, Lippo Centre, 89, Queensway Central, Hong Kong (hereinafter referred to as "Party A"), and Wedone Shanghai, Co., Ltd, organized and existing under the laws of P.R. China with its registered address at Rm. A75, Area A, Building 12, No.1-42, Lane 83, Hongxiang North Road, Wanxiang County, Pudong New District, Shanghai, P.R.China (hereinafter referred to as "Party B"), Shanghai Gold Pack Investment Management Co., Ltd, organized and existing under the laws of P.R. China with its registered address at Rm 35, Area B, No. 156 Jiankang Rd., Zhujing County, Jinshan District, Shanghai (hereinafter referred to as "Party C"), and XU Gang, an Australian citizen holding Australian passport of Passport No. E4118178 with his contact address at 34 Craigmore Drive, Kellyville, NSW 2155 Australia (hereina

China Jo-Jo Drugstores – CareRetail (HK) Holdings Limited Joint Venture Contract on Zhejiang Jiusong Pharmaceutical Management Co., Ltd. Made by and Between CareRetail (HK) Holdings Limited and Hangzhou Jiuzhou Grand Pharmacy Co., Ltd. Mu Lu Contents (February 10th, 2017)

Tiao Kuan Ye Ma Article Page Di [?] Tiao Ding Yi Definition 2 Di Er Tiao He Tong Shuang Fang Both parties to the contract 4 Di San Tiao Gong Si Company 4 Di Si Tiao Jing Ying Fan Wei Scope of business 5 Di Wu Tiao Tou Zi Zong E He Zhu Ce Zi Ben Total investment and registered capital 6 Di Liu Tiao Mei [?] Fang De Ze Ren responsibility of each party 9 Di Qi Tiao Dong Shi Hui He Jian Shi board of directors and supervisor 11 Di Ba Tiao Jing Ying Guan Li Zu Zhi operating and management ORGANIZATION 18 Di Jiu Tiao Lao Dong Guan Li LABOUR management 22 Di Shi Tiao Gong Si De You Hui Di Wei Preferential Status of the Company 23 Di Shi [?] Tiao Shui Wu , Cai Wu , Shen Ji He Li Run Fen Pei Taxation, finance, auditing

Aura Systems Inc – SINO-FOREIGN COOPERATIVE JOINT VENTURE CONTRACT for the Establishment and Operation of Jiangsu Shengfeng Mobile Power Technology (February 1st, 2017)

(1) Jiangsu AoLunTe Electrical Machinery Industrial Co., Ltd., a limited liability company incorporated and validly existing under the laws of People's Republic of China ("PRC" or "China"), with its registered office at Liyang, Jiangsu, PRC ("AoLunTe"); and (2) Aura Systems, Inc., a corporation organized and validly existing under the laws of Delaware, U.S., with its business place at 10541 Ashdale Street, Stanton, California 90680 ("Aura").

Sino-Foreign Joint Venture Contract (May 13th, 2016)

In accordance with the Law of the People s Republic of China on Joint Ventures Using Chinese and Foreign Investment (the "Joint Venture Law") and other relevant Chinese laws and regulations, China Xuzhou Shizhen Biotech Co Ltd and Globelink Ltd USA, in accordance with the principle of equality and mutual benefit and through friendly consultations, agree to jointly invest to set up a joint venture enterprise in Xuzhou Jiangsu of the People s Republic of China.

EQUITY JOINT VENTURE CONTRACT FOR COOPER (QINGDAO) TIRE CO. LTD. BY AND BETWEEN QINGDAO YIYUAN INVESTMENT CO., LTD. AND COOPER TIRE (CHINA) INVESTMENT CO., LTD AND COOPER TIRE HOLDING COMPANY January 4, 2016 (April 29th, 2016)

This Equity Joint Venture Contract (this Contract) is made and entered into in the Peoples Republic of China (China or the PRC) in accordance with the Joint Venture Laws and other relevant laws and regulations of the PRC, by and between:

Adient Ltd – JOINT VENTURE CONTRACT BETWEEN SHANGHAI YANFENG AUTOMOTIVE TRIM COMPANY, LTD. AND JOHNSON CONTROLS INTERNATIONAL, INC. October 22, 1997 Shanghai, Peoples Republic of China as Amended (April 27th, 2016)
LivaNova PLC – Joint Venture Contract (March 4th, 2016)
Hutchison China MediTech Ltd – English Translation THIRD AMENDMENT TO JOINT VENTURE CONTRACT (October 16th, 2015)

THIS THIRD AMENDMENT TO JOINT VENTURE CONTRACT (the Amendment No.3) is entered into by and between the following Parties in Shanghai Municipality, China as of June 19, 2012:

Hutchison China MediTech Ltd – English Translation SHANGHAI NO. 1 CHINESE MEDICINE CO. LTD. EQUITY JOINT VENTURE CONTRACT January 6, 2001 (October 16th, 2015)

[**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.

Hutchison China MediTech Ltd – English Translation AMENDMENT TO JOINT VENTURE CONTRACT (October 16th, 2015)

THIS AMENDMENT TO JOINT VENTURE CONTRACT (the Amendment) is entered into as of July 12, 2001 in Shanghai, China by and between the following parties:

Hutchison China MediTech Ltd – The Second Amendment to the Joint Venture Contract Relating to the Formation of Shanghai Hutchison Pharmaceuticals Limited (October 16th, 2015)

THIS SECOND AMENDMENT TO JOINT VENTURE CONTRACT (the Amendment No.2) is entered into by and between the following Parties in Shanghai Municipality, China on this 5th day of November 2007:

Hutchison China MediTech Ltd – English Translation FOURTH AMENDMENT TO JOINT VENTURE CONTRACT (October 16th, 2015)

THIS FOURTH AMENDMENT TO JOINT VENTURE CONTRACT (the Amendment No.4) is entered into by and between the following Parties in Shanghai Municipality, China on March 8, 2013:

Hutchison China MediTech Ltd – English Translation Hutchison Whampoa Sinopharm Pharmaceuticals (Shanghai) Company Limited Equity Joint Venture Contract (October 16th, 2015)

[**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.

Hutchison China MediTech Ltd – English Translation Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Equity Joint Venture Contract November 28, 2004 (October 16th, 2015)

[**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.

Natcore Technology Inc. – COOPERATIVE JOINT VENTURE CONTRACT for the Establishment of Natcore Technology (Zhuzhou) Co., Ltd. By and Between Zhuzhou Hexing Industrial Co., Ltd. And Natcore Asia Technology, Limited September 21, 2010 Confidential (September 25th, 2015)

This COOPERATIVE JOINT VENTURE CONTRACT (the Contract) is made and entered into as of September 20, 2010 in the Peoples Republic of China (the PRC or China) by and between the following parties in accordance with the Law of the Peoples Republic of China on Sino-Foreign Cooperative Joint Ventures and its implementing measures (the Cooperative Joint Venture Law), and other relevant Chinese laws and regulations adopted in principal place of the cooperative joint venture:

JOINT VENTURE CONTRACT THIS JOINT VENTURE AGREEMENT (The "Agreement"), Made and Entered Into as of This 31 St Day of August (September 4th, 2015)

2015, by Avra Inc., of 115, Pelham Commons Boulevard, Greenville, South Carolina, 29615 and Mango Pay SRL, of Plaza Orleans, 3 rd Floor, Av. Winston Churchill, Santo Domingo, Distrito Nacional, Dominican Republic.

Natcore Technology Inc. – COOPERATIVE JOINT VENTURE CONTRACT for the Establishment of Natcore Technology (Zhuzhou) Co., Ltd. By and Between Zhuzhou Hexing Industrial Co., Ltd. And Natcore Asia Technology, Limited September 21, 2010 Confidential (August 31st, 2015)

This COOPERATIVE JOINT VENTURE CONTRACT (the Contract) is made and entered into as of September 20, 2010 in the Peoples Republic of China (the PRC or China) by and between the following parties in accordance with the Law of the Peoples Republic of China on Sino-Foreign Cooperative Joint Ventures and its implementing measures (the Cooperative Joint Venture Law), and other relevant Chinese laws and regulations adopted in principal place of the cooperative joint venture:

Hutchison China MediTech Ltd – English Translation THIRD AMENDMENT TO JOINT VENTURE CONTRACT (August 21st, 2015)

THIS THIRD AMENDMENT TO JOINT VENTURE CONTRACT (the Amendment No.3) is entered into by and between the following Parties in Shanghai Municipality, China as of June 19, 2012:

Hutchison China MediTech Ltd – English Translation AMENDMENT TO JOINT VENTURE CONTRACT (August 21st, 2015)

THIS AMENDMENT TO JOINT VENTURE CONTRACT (the Amendment) is entered into as of July 12, 2001 in Shanghai, China by and between the following parties:

Hutchison China MediTech Ltd – English Translation Hutchison Whampoa Sinopharm Pharmaceuticals (Shanghai) Company Limited Equity Joint Venture Contract (August 21st, 2015)

[**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.

Hutchison China MediTech Ltd – English Translation FOURTH AMENDMENT TO JOINT VENTURE CONTRACT (August 21st, 2015)

THIS FOURTH AMENDMENT TO JOINT VENTURE CONTRACT (the Amendment No.4) is entered into by and between the following Parties in Shanghai Municipality, China on March 8, 2013:

Hutchison China MediTech Ltd – The Second Amendment to the Joint Venture Contract Relating to the Formation of Shanghai Hutchison Pharmaceuticals Limited (August 21st, 2015)

THIS SECOND AMENDMENT TO JOINT VENTURE CONTRACT (the Amendment No.2) is entered into by and between the following Parties in Shanghai Municipality, China on this 5th day of November 2007:

Hutchison China MediTech Ltd – English Translation Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Equity Joint Venture Contract November 28, 2004 (August 21st, 2015)

[**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.

Hutchison China MediTech Ltd – English Translation SHANGHAI NO. 1 CHINESE MEDICINE CO. LTD. EQUITY JOINT VENTURE CONTRACT January 6, 2001 (August 21st, 2015)

[**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.

Natcore Technology Inc. – COOPERATIVE JOINT VENTURE CONTRACT for the Establishment of Natcore Technology (Zhuzhou) Co., Ltd. By and Between Zhuzhou Hexing Industrial Co., Ltd. And Natcore Asia Technology, Limited September 21, 2010 Confidential (July 23rd, 2015)

This COOPERATIVE JOINT VENTURE CONTRACT (the Contract) is made and entered into as of September 20, 2010 in the Peoples Republic of China (the PRC or China) by and between the following parties in accordance with the Law of the Peoples Republic of China on Sino-Foreign Cooperative Joint Ventures and its implementing measures (the Cooperative Joint Venture Law), and other relevant Chinese laws and regulations adopted in principal place of the cooperative joint venture:

Dated May 30, 2014 Baoding Tianwei Baobian Electric Co., Ltd., Baoting Tianwei Group Co., Ltd. And Yingli Green Energy Holding Company Limited Joint Venture Contract Contents (May 15th, 2015)